Dermira to Present at the 2015 Leerink Global Healthcare Conference
January 29, 2015 16:05 ET
|
Dermira, Inc.
MENLO PARK, Calif., Jan. 29, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...
Dermira and UCB Announce Start of Phase 3 Program for CIMZIA(R) (certolizumab pegol) in Psoriasis
January 08, 2015 02:00 ET
|
Dermira, Inc.
Phase 3 program aims to address patient need for alternative treatment options in moderate-to-severe psoriasis
Program includes the first Phase 3 study in psoriasis comparing two...
Dermira Added to Russell 2000(R) Index
December 22, 2014 08:00 ET
|
Dermira, Inc.
MENLO PARK, Calif., Dec. 22, 2014 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated medical dermatology products...
Dermira Reports Third Quarter 2014 Financial Results and Provides Corporate Update
November 12, 2014 16:05 ET
|
Dermira, Inc.
REDWOOD CITY, Calif., Nov. 12, 2014 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated medical dermatology...
Dermira Prices Initial Public Offering
October 02, 2014 21:37 ET
|
Dermira, Inc.
REDWOOD CITY, Calif., Oct. 2, 2014 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated medical dermatology products...